関連する実験動画
Updated: Feb 23, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
82.0K
肺結核の初期診断試験としてのXpert MTB/RIFアッセイ:多センターの有望ランダム化プラグマティック試験
Wei-Chang Huang1,2,3, Yi-Wen Huang4,5, Chih-Bin Lin6,7
1Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, 402, Taiwan.
Scientific reports
|February 21, 2026
まとめ
肺結核の初期診断のためのXpert MTB/RIFアッセイの拡張は,台湾における結核管理の成果を改善しなかった. この研究では,Xpertテストを前もって使用する際の診断率,治療開始,または成功の有意な違いは見つかりませんでした.
科学分野:
- 医療診断 医療診断
- 感染症 感染症は感染症です.
- 公衆衛生は公衆衛生である.
背景:
- 核酸増幅テスト (NAAT) は,台湾で肺結核 (TB) の診断に選択的に使用されました.
- Xpert MTB/RIFアッセイは,結核の迅速な診断ツールです.
研究 の 目的:
- 結核管理における初期診断テストとして,Xpert MTB/RIFアッセイの拡大使用の影響を評価する.
- 直接のXpert検査が,通常のケアと比較して,TBの診断,治療開始,患者のアウトカムを改善するかどうかを評価する.
主な方法:
- ランダム化制御試験で,肺結核の疑いのある6835人の患者が参加した.
- グループBは直ちにXpert MTB/RIFテストを受け,グループCは通常のケアを受けた.
- 測定されたアウトカムには,結核診断の割合,治療前の死亡率,治療開始までの時間,治療の成功率が含まれています.
主要な成果:
- 直接Xpertグループ (グループB) と通常治療グループ (グループC) の間で,診断された活性結核の割合 (3.1%対2.7%) で有意な差異は観察されなかった.
- 抗結核治療前の死亡率 (2.3%対5.1%),唾液出血から治療開始までの平均時間 (7.0対6.0日),治療の成功率 (73.8%対81.8%) は有意な差異はなかった.
- 試験では,初期Xpert MTB/RIFテストを拡大して,低確率のTBの予備試験を受けた患者を対象に,台湾でのTB制御にプラスの影響を示す証拠は見つかりませんでした.
結論:
- 台湾における肺結核の初期診断検査として,Xpert MTB/RIFアッセイの拡大使用は,結核のコントロールに肯定的な影響を示さなかった.
- 研究結果は,TBのプレテストの可能性が低い患者の場合,即時のXpert検査は,標準的な診断経路と比較して,主要な管理および結果指標を大幅に変更しないことを示唆しています.
キーワード:
診断 診断 診断するプラグマティック・トライアル結核 (TB) についてXpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert MTB/RIFは,Xpert関連する概念動画
Pulmonary Tuberculosis IV
560
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560
Pulmonary Tuberculosis V
663
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
663
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K

